Clinical diagnosis of cyanide poisoning is complicated by the lack of
an easy, convenient assay for cyanide concentration in blood. Therapy
may be delayed with unconfirmed diagnosis because the conventional ant
idote to cyanide poisoning exposes patients to substantial risks. We d
eveloped a new spectrophotometric assay to measure cyanide by extracti
on into a sodium hydroxide trap, followed by the addition of exogenous
methemoglobin as a colormetric indicator. Samples of blood from 15 he
althy subjects and 5 patients who had received prolonged nitroprusside
infusions were assayed. To optimize assay characteristics, methemoglo
bin concentrations, pH, temperature, incubation time, and buffer stren
gths were varied. Duplicate samples were assayed by using the polarogr
aphic method for assay validation. Over a range from 300 ng/mL to 7 mu
g/mL, the correlation between methods was r = 0.983. Interassay and i
ntraassay variability were 5% and 2%, respectively. Samples drawn from
the five patients and tested by using both methods yielded a correlat
ion of r = 0.978. This new assay for cyanide in blood may greatly faci
litate the diagnosis and treatment of cyanide ingestion. The use of me
themoglobin as the colorimetric indicator in the assay contributes to
its low cost and ease of use. Implications: Cyanide, an important fact
or in death from burn-related inhalation injury, is difficult and time
-consuming to measure. We developed a new, rapid blood test for cyanid
e using methemoglobin as a colormetric indicator. A rapid, accessible
test for cyanide may speed the diagnosis and treatment of cyanide pois
oning.